These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
267 related articles for article (PubMed ID: 35929879)
21. Iron oxide nanoparticles - In vivo/in vitro biomedical applications and in silico studies. Nedyalkova M; Donkova B; Romanova J; Tzvetkov G; Madurga S; Simeonov V Adv Colloid Interface Sci; 2017 Nov; 249():192-212. PubMed ID: 28499604 [TBL] [Abstract][Full Text] [Related]
22. Stimuli-controllable iron oxide nanoparticle assemblies: Design, manipulation and bio-applications. Low LE; Lim HP; Ong YS; Siva SP; Sia CS; Goh BH; Chan ES; Tey BT J Control Release; 2022 May; 345():231-274. PubMed ID: 35306119 [TBL] [Abstract][Full Text] [Related]
23. Recent trends in preparation and biomedical applications of iron oxide nanoparticles. Meng YQ; Shi YN; Zhu YP; Liu YQ; Gu LW; Liu DD; Ma A; Xia F; Guo QY; Xu CC; Zhang JZ; Qiu C; Wang JG J Nanobiotechnology; 2024 Jan; 22(1):24. PubMed ID: 38191388 [TBL] [Abstract][Full Text] [Related]
24. Hyperthermia treatment of cancer cells by the application of targeted silk/iron oxide composite spheres. Kucharczyk K; Kaczmarek K; Jozefczak A; Slachcinski M; Mackiewicz A; Dams-Kozlowska H Mater Sci Eng C Mater Biol Appl; 2021 Jan; 120():111654. PubMed ID: 33545822 [TBL] [Abstract][Full Text] [Related]
25. Glucose-coated superparamagnetic iron oxide nanoparticles prepared by metal vapour synthesis are electively internalized in a pancreatic adenocarcinoma cell line expressing GLUT1 transporter. Barbaro D; Di Bari L; Gandin V; Evangelisti C; Vitulli G; Schiavi E; Marzano C; Ferretti AM; Salvadori P PLoS One; 2015; 10(4):e0123159. PubMed ID: 25874906 [TBL] [Abstract][Full Text] [Related]
26. Fe Wang S; Li J; Chen L; Zeng J; Gao M J Phys Chem Lett; 2024 Aug; 15(34):8861-8866. PubMed ID: 39169277 [TBL] [Abstract][Full Text] [Related]
27. New Insights into Biocompatible Iron Oxide Nanoparticles: A Potential Booster of Gene Delivery to Stem Cells. Zhang T; Xu Q; Huang T; Ling D; Gao J Small; 2020 Sep; 16(37):e2001588. PubMed ID: 32725792 [TBL] [Abstract][Full Text] [Related]
28. A 'degradable' poly(vinyl alcohol) iron oxide nanoparticle hydrogel. Bannerman AD; Li X; Wan W Acta Biomater; 2017 Aug; 58():376-385. PubMed ID: 28499634 [TBL] [Abstract][Full Text] [Related]
29. Magnetic field enhanced convective diffusion of iron oxide nanoparticles in an osmotically disrupted cell culture model of the blood-brain barrier. Sun Z; Worden M; Wroczynskyj Y; Yathindranath V; van Lierop J; Hegmann T; Miller DW Int J Nanomedicine; 2014; 9():3013-26. PubMed ID: 25018630 [TBL] [Abstract][Full Text] [Related]
30. Toward absolute quantification of iron oxide nanoparticles as well as cell internalized fraction using multiparametric MRI. Girard OM; Ramirez R; McCarty S; Mattrey RF Contrast Media Mol Imaging; 2012; 7(4):411-7. PubMed ID: 22649047 [TBL] [Abstract][Full Text] [Related]
31. Hybrid gold-iron oxide nanoparticles as a multifunctional platform for biomedical application. Hoskins C; Min Y; Gueorguieva M; McDougall C; Volovick A; Prentice P; Wang Z; Melzer A; Cuschieri A; Wang L J Nanobiotechnology; 2012 Jun; 10():27. PubMed ID: 22731703 [TBL] [Abstract][Full Text] [Related]
32. Interactions of Common Biological Buffers with Iron Oxide Nanoparticles. Cross SN; Al-Feghali AH; Blum AS Langmuir; 2023 Jun; 39(22):7632-7641. PubMed ID: 37204470 [TBL] [Abstract][Full Text] [Related]
33. Programmed near-infrared light-responsive drug delivery system for combined magnetic tumor-targeting magnetic resonance imaging and chemo-phototherapy. Feng Q; Zhang Y; Zhang W; Hao Y; Wang Y; Zhang H; Hou L; Zhang Z Acta Biomater; 2017 Feb; 49():402-413. PubMed ID: 27890732 [TBL] [Abstract][Full Text] [Related]
34. In vivo delivery, pharmacokinetics, biodistribution and toxicity of iron oxide nanoparticles. Arami H; Khandhar A; Liggitt D; Krishnan KM Chem Soc Rev; 2015 Dec; 44(23):8576-607. PubMed ID: 26390044 [TBL] [Abstract][Full Text] [Related]
35. Magnetic iron oxide nanoparticles for drug delivery: applications and characteristics. Vangijzegem T; Stanicki D; Laurent S Expert Opin Drug Deliv; 2019 Jan; 16(1):69-78. PubMed ID: 30496697 [TBL] [Abstract][Full Text] [Related]
36. Iron oxide nanoparticles/nanocomposites derived from steel and iron wastes for water treatment: A review. Jjagwe J; Olupot PW; Carrara S J Environ Manage; 2023 Oct; 343():118236. PubMed ID: 37235992 [TBL] [Abstract][Full Text] [Related]
37. Lysosomal iron liberation is responsible for the vulnerability of brain microglial cells to iron oxide nanoparticles: comparison with neurons and astrocytes. Petters C; Thiel K; Dringen R Nanotoxicology; 2016; 10(3):332-42. PubMed ID: 26287375 [TBL] [Abstract][Full Text] [Related]
38. Prussian Blue Staining to Visualize Iron Oxide Nanoparticles. Bitonto V; Garello F; Scherberich A; Filippi M Methods Mol Biol; 2023; 2566():321-332. PubMed ID: 36152263 [TBL] [Abstract][Full Text] [Related]
39. Antimicrobial magnetic nanoparticles based-therapies for controlling infectious diseases. Rodrigues GR; López-Abarrategui C; de la Serna Gómez I; Dias SC; Otero-González AJ; Franco OL Int J Pharm; 2019 Jan; 555():356-367. PubMed ID: 30453018 [TBL] [Abstract][Full Text] [Related]
40. Highly Optimized Iron Oxide Embedded Poly(Lactic Acid) Nanocomposites for Effective Magnetic Hyperthermia and Biosecurity. Ryu C; Lee H; Kim H; Hwang S; Hadadian Y; Mohanty A; Park IK; Cho B; Yoon J; Lee JY Int J Nanomedicine; 2022; 17():31-44. PubMed ID: 35023918 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]